Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific dòng tiền tự do Non-GAAP (Free Cash Flow = Operating Cash Flow − Net CapEx) ($M)
IR Financial Reconciliation Package & SEC 8-K
Latest, FY2025
6,337
Period ended Dec 31, 2025
Change on a year earlier
-13.5%
7,324 in FY2024
History
7 years
Since FY2013
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Dòng tiền tự do Non-GAAP (Free Cash Flow = Operating Cash Flow − Net CapEx) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6,337 | -13.5% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 7,324 | +4.4% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 7,014 | +1.1% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 6,935 | +1.9% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2021 | Dec 31, 2021 | 6,809 | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2015 | Dec 31, 2015 | 2,546 | – | 2026 Investor Day Financial Appendix (2026-05-20) ↗ |
| FY2013 | Dec 31, 2013 | 1,826 | – | 2024 Investor Day Financial Appendix (2024-09-19) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Dòng tiền tự do Non-GAAP (Free Cash Flow = Operating Cash Flow − Net CapEx) ($M), annual FY2013–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fcf_non_gaap
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.